Richard Mularski to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Richard Mularski has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.054
-
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. Ann Intern Med. 2022 12; 175(12):1716-1727.
Score: 0.054